Poor outcome and non-response to DMARD therapy: A study of 6870 rheumatoid arthritis patients.

被引：0
|
作者：
Wolfe, F
Pincus, T
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
695
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [1] PREDICTION OF NON-RESPONSE TO METHOTREXATE THERAPY IN THE RHEUMATOID ARTHRITIS MEDICATION STUDY (RAMS)
    Sergeant, J. C.
    Hyrich, K. L.
    Anderson, J.
    Kopec-Harding, K.
    Hope, H. F.
    Barton, A.
    Verstappen, S. M. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 57 - 58
  • [2] UNDERSTANDING NON-RESPONSE TO INFLIXIMAB IN RHEUMATOID ARTHRITIS: PREDICTING SUBSEQUENT OUTCOME
    Buch, M. H.
    Seto, Y.
    Bingham, S. J.
    Bejarano, V.
    Bryer, D.
    White, J.
    Emery, P.
    [J]. RHEUMATOLOGY, 2004, 43 : 43 - 44
  • [3] Rheumatoid factor and the initiation of DMARD therapy in patients with early rheumatoid arthritis
    Nikolaisen, C
    Kvien, TK
    Mikkelsen, K
    Kaufmann, C
    Ridevand, E
    Nossent, HC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 195 - 195
  • [4] MHC association with response to infliximab therapy in rheumatoid arthritis patients.
    Fernandez-Gutierrez, B
    Martinez, A
    Salido, M
    Bonilla, G
    Pascual-Salcedo, D
    de la Concha, EG
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S128 - S128
  • [5] CHARACTERISTICS OF PATIENTS RECEIVING DMARD THERAPY FOR RHEUMATOID ARTHRITIS MANAGEMENT
    Boytsov, N. N.
    Bhattacharya, R.
    Saverno, K. R.
    Dixon, L.
    Abbott, P. L.
    Zhang, X.
    Larmore, C. J.
    Datar, M.
    Gaich, C. L.
    Nair, R.
    [J]. VALUE IN HEALTH, 2018, 21 : S201 - S202
  • [6] EFFECTIVENESS AND COSTS OF CONVENTIONAL DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Buitrago-Garcia, D.
    Villarreal, L.
    Alvis-Zakzuk, N.
    Carrasquilla, M.
    Alvis Guzman, N.
    [J]. VALUE IN HEALTH, 2018, 21 : S196 - S196
  • [7] Understanding non-response to infliximab: Subtypes of non-response; Its importance in the pathogenesis of rheumatoid arthritis.
    Buch, MH
    Seto, Y
    Bingham, SJ
    Bejarano, V
    Bryer, D
    Smith, S
    Isaacs, J
    Emery, P
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S701 - S701
  • [8] THE DAS28-P INDEX AS A PREDICTOR OF POOR SUBJECTIVE RESPONSE TO DMARD THERAPY IN EARLY RHEUMATOID ARTHRITIS
    Whittle, S.
    Menz, F.
    Lester, S.
    Proudman, S.
    Hill, C.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 9 - 9
  • [9] Outcome of a patient with rheumatoid arthritis treated with homeopathic drugs without DMARD therapy
    Keysser, Gernot
    [J]. MEDIZINISCHE KLINIK, 2008, 103 (01) : 36 - 37
  • [10] Utility of outcome measures in decisions to change DMARD therapy for rheumatoid arthritis.
    Canvin, JMG
    Chalmers, IM
    El-Gabalawy, HS
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S126 - S126
12345